Ruan Pimenta, Nayara I Viana, Gabriel A Dos Santos, Patrícia Candido, Vanessa R Guimarães, Poliana Romão, Iran A Silva, Juliana A de Camargo, Diná M Hatanaka, Paula G S Queiroz, Alexandre Teruya, Leandro Echenique, Bruno A M P Besen, Katia R M Leite, Victor Srougi, Miguel Srougi, Sabrina T Reis
{"title":"MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19.","authors":"Ruan Pimenta, Nayara I Viana, Gabriel A Dos Santos, Patrícia Candido, Vanessa R Guimarães, Poliana Romão, Iran A Silva, Juliana A de Camargo, Diná M Hatanaka, Paula G S Queiroz, Alexandre Teruya, Leandro Echenique, Bruno A M P Besen, Katia R M Leite, Victor Srougi, Miguel Srougi, Sabrina T Reis","doi":"10.22099/mbrc.2021.40555.1631","DOIUrl":null,"url":null,"abstract":"<p><p>COVID-19 represents a public health emergency, whose mechanism of which is not fully understood. It is speculated that microRNAs may play a crucial role in host cells after infection by SARS-CoV-2. Thus, our study aimed to analyze the expression of miR-200c-3p in saliva samples from patients with COVID-19. One handred eleven samples from patients with COVID-19 were divided into 4 groups. Group I: 39 patients negative for Covid-19; Group II: 37 positive and symptomatic patients, with no indication of hospitalization; Group III: 21 patients with respiratory disorders (hospitalized); Group IV: 14 patients with severe conditions (oxygen therapy). The expression levels of miR-200c-3p were determined using qPCR. We found greater expression of miR-200c-3p in patients in group IV (<i>p</i><0.0001), and also verified that patients aged ≥42 years had a higher expression of this miR (<i>p</i>=0.013). Logistic regression analysis revealed that the expression of miR-200c-3p and systemic arterial hypertension are factors independently associated with patients in group IV (<i>p</i><0.0001). Our results suggest that miR-200c-3p is a predictor of severity independent of COVID-19 risk factors, which could represent a way of screening patients affected by SARS-CoV-2.</p>","PeriodicalId":19025,"journal":{"name":"Molecular Biology Research Communications","volume":"10 3","pages":"141-147"},"PeriodicalIF":1.5000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340313/pdf/","citationCount":"22","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Biology Research Communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22099/mbrc.2021.40555.1631","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 22
Abstract
COVID-19 represents a public health emergency, whose mechanism of which is not fully understood. It is speculated that microRNAs may play a crucial role in host cells after infection by SARS-CoV-2. Thus, our study aimed to analyze the expression of miR-200c-3p in saliva samples from patients with COVID-19. One handred eleven samples from patients with COVID-19 were divided into 4 groups. Group I: 39 patients negative for Covid-19; Group II: 37 positive and symptomatic patients, with no indication of hospitalization; Group III: 21 patients with respiratory disorders (hospitalized); Group IV: 14 patients with severe conditions (oxygen therapy). The expression levels of miR-200c-3p were determined using qPCR. We found greater expression of miR-200c-3p in patients in group IV (p<0.0001), and also verified that patients aged ≥42 years had a higher expression of this miR (p=0.013). Logistic regression analysis revealed that the expression of miR-200c-3p and systemic arterial hypertension are factors independently associated with patients in group IV (p<0.0001). Our results suggest that miR-200c-3p is a predictor of severity independent of COVID-19 risk factors, which could represent a way of screening patients affected by SARS-CoV-2.
期刊介绍:
“Molecular Biology Research Communications” (MBRC) is an international journal of Molecular Biology. It is published quarterly by Shiraz University (Iran). The MBRC is a fully peer-reviewed journal. The journal welcomes submission of Original articles, Short communications, Invited review articles, and Letters to the Editor which meets the general criteria of significance and scientific excellence in all fields of “Molecular Biology”.